FRONTOTEMPORAL DEMENTIA
Clinical trials for FRONTOTEMPORAL DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new FRONTOTEMPORAL DEMENTIA trials appear
Sign up with your email to follow new studies for FRONTOTEMPORAL DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug TPN-101 tested in ALS and dementia patients with C9orf72 gene mutation
Disease control CompletedThis study tested a drug called TPN-101 in 42 people with ALS or frontotemporal dementia caused by a specific gene change (C9orf72). The main goal was to check if the drug is safe and tolerable over 48 weeks. Researchers also looked at how the drug moves in the body and whether i…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE2 • Sponsor: Transposon Therapeutics, Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New drug targets genetic dementia in small trial
Disease control CompletedThis study tested a drug called AL001 in 33 people who carry a gene mutation that causes frontotemporal dementia, a brain disease that affects personality and language. The goal was to see if the drug is safe and how it affects certain proteins in the body. The trial was open-lab…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE2 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New online tool aims to ease dementia caregiver stress
Symptom relief CompletedThis study tested an online tool called WeCareAdvisor that helps caregivers of people with dementia manage behavioral and psychological symptoms. 262 caregivers used the tool for 6 months, with some receiving extra prompts. The goal was to see if it reduces caregiver distress and…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: Drexel University • Aim: Symptom relief
Last updated Jun 23, 2026 11:56 UTC
-
Phone-Based dementia care cuts ER visits and boosts quality of life
Symptom relief CompletedThis study tested a dementia care program delivered by phone and web, where trained navigators helped patients and caregivers manage care. Over 1,200 people with dementia and their caregivers took part across six health systems. The goal was to see if this approach could improve …
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 22, 2026 12:07 UTC
-
Video program eases burden for FTD caregivers
Symptom relief CompletedThis study tested a video-based program called STELLA-FTD to help family caregivers of people with frontotemporal dementia (FTD). Sixteen caregivers participated in the program, which aimed to reduce their stress and improve their quality of life. The approach used videoconferenc…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 22, 2026 12:01 UTC
-
Sensors track apathy in dementia patients in real life
Knowledge-focused CompletedThis pilot study tested whether wearable sensors can measure apathy in people with frontotemporal dementia and healthy volunteers. Researchers used video recordings and motion sensors to track behaviors like lying, sitting, and energy use. The goal was to see if this technology c…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
Study dives into how dementia affects personal memory recall
Knowledge-focused CompletedThis study looked at how people with Alzheimer's disease or a type of frontotemporal dementia recall personal memories. Researchers analyzed whether memories were specific events or more general. The goal was to better understand memory changes in these conditions, not to test a …
Matched conditions: FRONTOTEMPORAL DEMENTIA
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:51 UTC
-
What’s it like to live with bvFTD? researchers ask patients directly
Knowledge-focused CompletedThis study interviewed 26 adults who either have behavioral variant frontotemporal dementia (bvFTD) or carry a gene that puts them at risk. The goal was to learn how the condition affects daily life, emotions, and coping. No treatment or medication was tested—just listening and g…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:05 UTC
-
Large study maps genetic roots of rare dementia
Knowledge-focused CompletedThis study examined over 2,200 people with frontotemporal dementia (FTD) or symptoms of it to find out how many cases are linked to specific genes. Researchers collected genetic samples to better understand the causes of this rare brain disease. The goal was to gather knowledge, …
Matched conditions: FRONTOTEMPORAL DEMENTIA
Sponsor: CENTOGENE GmbH Rostock • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Brain study reveals how frontal lobe damage affects reasoning
Knowledge-focused CompletedThis study looked at how the prefrontal cortex helps us think in analogies and categories. Researchers tested healthy volunteers and patients with frontotemporal dementia or progressive supranuclear palsy using tasks that measure reaction time and accuracy. They also used brain s…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Tiny brain clues may reveal how dementias differ
Knowledge-focused CompletedThis study examined 186 people with Alzheimer's, Lewy body, frontotemporal, or corticobasal dementia, plus healthy controls, to see if subtle physical signs (like coordination or reflexes) differ between dementia types. Participants had simple exams and cognitive tests. The goal …
Matched conditions: FRONTOTEMPORAL DEMENTIA
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC